Limited Competition: Tribal Institutional Review Board Establishment and Enhancement (TIRBEE)
Forecast
National Institutes of Health plans to offer grants to tribes. It is a forecast: the notice is expected around March 25, 2027, with applications due around May 25, 2027.
From the official notice on Grants.gov, last changed September 14, 2026. Checked October 31, 2026.
- Award ceilingnot stated
- Award floornot stated
- Expected awardsnot stated
- Total fundingnot stated
- Cost sharingNot required
- Funding typeGrant
Key dates
| Forecast posted | September 14, 2026 |
|---|---|
| Expected posting | March 25, 2027 |
| Expected deadline | May 25, 2027 |
| Expected award date | April 1, 2028 |
Add the deadline to your calendar
Who can apply
This opportunity is open to tribes.
- Native American tribal governments (Federally recognized)
- Others (see text field entitled "Additional Information on Eligibility" for clarification)
Other Eligible ApplicantsA federally-recognized AI/AN Tribe, as defined under 25 U.S.C. 1603(14); orA Tribal college or university, a Tribal health program, or a Tribal organization as defined under 25 U.S.C. 1603 (24), (25), and (26), respectively; orA consortium of two or more of those Tribal entities. Foreign Organizations/Foreign CollaborationsAn application may include foreign components only if one or more federally-recognized Tribes with ancestral catchment areas crossing the U. S. border will participate in the proposed Tribal Institutional Review Board Establishment and Enhancement (TIRBEE) application.
Is this a realistic fit?
- No cost sharing or match is required.
What the grant funds
The Tribal Institutional Review Board Establishment and Enhancement (TIRBEE) Notice of Funding Opportunity will enable federally-recognized Tribes or Tribal Entities to establish or enhance Institutional Review Boards. TIRBEE builds the capacity and infrastructure for biomedical research involving human participants in federally-recognized Tribal communities by expanding their Institutional Review Board review and oversight capabilities. This is a Forecast for a Limited Competition that will invite application(s) from eligible organization(s) to apply. Please see Eligibility Section for additional information. In accordance with NIH standard peer-review processes, the application(s) will be peer-reviewed, and only meritorious application(s) will be considered.
How to apply
- Read the full notice and attachments on Grants.gov. The notice is the official source for deadlines and requirements.
- Make sure your organization has an active SAM.gov registration and Unique Entity ID; registration can take several weeks.
- Register on Grants.gov and submit through Workspace before the deadline and time given in the notice. Our application guide walks through each step.
Questions go to NIGMS TIRBEE Program, NIGMS_TIRBEE_Program@nigms.nih.gov, Please contact via e-mail.
Questions people ask
Who can apply for Limited Competition: Tribal Institutional Review Board Establishment and Enhancement (TIRBEE)?
National Institutes of Health accepts applications from tribes. The notice adds further conditions, so read its eligibility section.
What is the deadline for Limited Competition: Tribal Institutional Review Board Establishment and Enhancement (TIRBEE)?
Expected deadline May 25, 2027. Confirm the date and time in the official notice on Grants.gov.
Similar open grants
- Continuation of the Collaborative Islet Transplantation Registry (U01 Clinical Trial Not allowed)
- BRAIN Initiative Cell Atlas Network (BICAN): Coordinating Unit for Biostatistics, Informatics, and Engagement (CUBIE)
- Centers without Walls for mechanisms of neurodegeneration in Alzheimer’s disease-related dementias (ADRD)
- Expanding the Therapeutic Pipeline for Treating and Preventing Alzheimer's Disease and Related Dementias: Preclinical Validation and Drug Discovery for Novel Candidate Targets (U01 Clinical Trial Not Allowed)
- Systematic Testing of Radionuclides in Preclinical Experiments (STRIPE, RP1 Clinical Trial Not Allowed)
- Exposomic Contributions to ADRD Pathology and Resilience